In Monday’s weekly digest, we flagged early signs that accreditation reform was emerging in procurement language and late-stage buying conversations across higher education. What was initially easy to dismiss as policy noise is now showing up in real deals, changing how institutions evaluate risk, involve stakeholders, and ultimately decide whether they can move forward.

This deep dive builds on that signal and explains why deals that feel approved are stalling, why objections are emerging late in the process, and what vendors need to change now to avoid being quietly filtered out in 2026 buying cycles.

Pipelines are still there. Projects are still funded. Buyers are still engaged. In many cases, functional teams have already selected a preferred vendor. And yet, deals that would historically have closed are now stretching by months, shrinking in scope, or going quiet after verbal alignment.

The reason is not macro uncertainty. It is not ARPA digestion. And it is not indecision.

What has changed is when institutional risk shows up in the buying process.

Over the past six to nine months, accreditation and administrative capability concerns have moved from background assumptions to explicit gating factors. Institutions are increasingly treating vendor selection as something that must be defensible to accreditors, auditors, and federal reviewers not just usable by the department that initiated the purchase.

That shift matters because those stakeholders do not sit at the table early.

In many deals, the academic unit, IT team, or functional owner still runs the initial evaluation. Product fit, implementation feasibility, and budget alignment look acceptable. The vendor believes the deal is progressing normally.

The stall happens later, when the decision has to survive institutional scrutiny.

At that point, new questions appear. Not about features or outcomes, but about exposure.

These questions are not hypothetical. They are being asked now because recent federal and accreditation-linked regulatory changes have raised the cost of getting this wrong. Institutions that fail administrative capability reviews or mismanage third-party risk face real consequences, including funding disruption and Title IV exposure. As a result, precautionary behavior has replaced discretionary buying.

Vendors often assume that if accreditation were truly a blocker, it would surface early or appear explicitly in the RFP.

In practice, the opposite is happening.

Accreditation language is increasingly embedded in procurement criteria, risk assessments, and contract approvals rather than highlighted in early discovery. It shows up as scored requirements around governance, evidence standards, and institutional accountability. It also brings new reviewers into the process legal, audit, institutional research, compliance officers who were not involved when the solution was first evaluated.

By the time those stakeholders engage, the question is no longer whether the solution works.

It is whether the institution can defend choosing it.

That is why vendors are hearing objections late, after months of progress. And that is why those objections are often framed as requests for more time, more review, or more documentation rather than outright rejection.

The institution is not saying no. It is deciding whether it can say yes safely.

Many vendors describe current deals as delayed rather than lost. That framing is accurate, but misleading if interpreted as temporary.

What the research shows is a structural change in how higher education organizations manage risk. Governance, compliance, and accreditation considerations are now being priced into sales cycles. Expanded stakeholder involvement, longer diligence phases, and higher proof thresholds are becoming standard rather than exceptional.

In other words, the delay is not the anomaly. The old speed is.

Vendors that treat this as a passing slowdown will continue to misread pipeline health. Vendors that recognize it as a permanent shift in how buying decisions are justified will adjust how they sell, what they prove, and who they sell to.

The rest of this article explains how accreditation pressure is reshaping RFPs and evaluations, why familiar proof points no longer work, and what vendors need to change now to avoid being quietly filtered out of 2026 deals.

Over the past several months, institutions have begun translating accreditation and administrative capability pressure into concrete buying rules. These rules are not always labeled accreditation requirements, but they function that way in practice. They determine who advances, who stalls, and who never makes it to final approval.

Historically, many institutions assumed that reputable vendors would be broadly compliant. Accreditation was something the institution managed, not something vendors had to explicitly support.

That assumption no longer holds.

Recent procurement documents show accreditation readiness and governance alignment appearing as explicit evaluation criteria.

In some cases, the language is direct, for example the ability to meet accreditation requirements or support compliance obligations. In others, it is embedded in requirements around evidence standards, documentation, audit support, and institutional accountability.

The effect is the same. Vendors are now being evaluated on whether their solution can be defended during accreditation review or federal audit, not just whether it performs its intended function.

This is why vendors that appear competitive on features and price are still losing ground. They are being scored on dimensions they did not realize were decisive.

Another quiet but consequential shift is how institutions define vendor risk.

Risk is no longer limited to uptime, data security, or implementation failure. It now includes audit exposure, third-party liability, and the risk that a vendor relationship could trigger scrutiny under administrative capability or third-party servicer guidance.

This has two implications for buying behavior.

First, institutions are asking different questions. They want to know how vendors document processes, handle compliance obligations, and support institutional reporting requirements. They are less interested in assurances and more interested in what can be produced under review.

Second, institutions are involving different people. Legal, audit, compliance, and institutional research teams are now routinely pulled into evaluations that were previously owned by IT or academic units. These stakeholders are not optimizing for innovation or speed. They are optimizing for defensibility.

When those teams enter the process, the bar changes.

Many vendors assume that if an RFP does not explicitly mention accreditation, it is not a primary concern. That assumption is increasingly dangerous.

Institutions are using RFPs to pre-filter vendors on governance and evidence readiness without calling it accreditation screening. Requirements tied to federal evidence standards, validation of outcomes, documentation practices, and governance certifications all serve the same purpose. They reduce institutional exposure later.

In several recent cases, accreditation alignment is listed as a scored category alongside financial and operational criteria. In others, it appears as a condition of award or as supplemental documentation required before contract execution.

The practical outcome is that vendors who cannot clearly map their offering to institutional accountability frameworks are filtered out quietly. They may be invited to present, asked follow-up questions, or even named a preferred option, but they do not make it through final approval.

This change is not coming from procurement alone.

Presidents, provosts, and system leaders are increasingly accountable for certifying compliance with federal and accreditation-linked requirements. That accountability is flowing downward. Institutional research, compliance, and governance functions are being asked to reduce risk proactively rather than respond after the fact.

Procurement teams are implementing that mandate by tightening evaluation criteria. They are not trying to slow buying. They are trying to prevent decisions that cannot be defended later.

For vendors, this distinction matters. What feels like bureaucratic friction is, from the institution’s perspective, a rational response to rising consequences.

The result is a buying environment where deals are not lost because the product is weak, but because the institution cannot justify choosing it under scrutiny.

The next section explains why this shift is colliding with traditional sales proof points and why objections are surfacing only after vendors believe they have already won.

Vendors are not losing deals because their products stopped working, but because the proof they bring into late-stage reviews does not answer the questions institutions are now required to ask.

The research shows a consistent pattern: functional approval happens first, institutional scrutiny happens later. Traditional proof points satisfy the first stage. They fail the second.

Many vendors enter final-stage reviews with the same assets that have closed deals for years: peer references, marquee logos, and outcome metrics.

Those assets still matter to departmental buyers. They matter far less to institutional reviewers.

Recent procurement documents and governance reviews show institutions shifting toward evidence that aligns with federal and accreditation-linked standards. RFPs increasingly require vendors to demonstrate that claims meet recognized evidence thresholds or can be substantiated under audit. Internal vendor research or anecdotal success stories are no longer sufficient.

In multiple cases, institutions explicitly required vendors to show how their product supports evidence-based validation tied to federal programs or accreditation criteria. Vendors that could not demonstrate this alignment were not formally rejected. They were simply not advanced.

The research shows that objections are surfacing when legal, audit, or institutional research teams enter the process.

At that point, buyers are not asking whether the product improves outcomes. They are asking whether the institution can explain, document, and defend the decision during review.

Examples from recent disclosures and procurement behavior include questions such as:

These questions are appearing late because they are not part of functional evaluation. They are part of institutional risk management.

When vendors cannot answer them clearly, deals stall even if the product has already been approved in principle.

The research also shows that AI has introduced a new class of late-stage scrutiny.

Institutions are increasingly requiring legal and IT sign-off for AI-enabled purchases. Even vendors with limited or assistive AI features are being pulled into governance reviews focused on explainability, human oversight, and audit readiness.

Several vendors reported that AI slowed new evaluations not because institutions rejected the technology, but because it required additional policy and procurement work before approval. Buyers paused deals while they established governance frameworks rather than risk moving forward without defensible controls.

This explains why some deals appear healthy, then freeze without explanation. The institution is not renegotiating value. It is deciding whether it can safely proceed.

The research consistently describes deals as delayed rather than canceled. That framing is accurate but incomplete.

Institutions are reluctant to reject solutions that have internal support and budget alignment. Instead, they slow the process when they cannot yet defend the decision under scrutiny. Requests for more documentation, more review cycles, or additional approvals are a signal that the proof threshold has not been met.

In many cases, those pauses persist indefinitely. The institution does not choose a different vendor. It simply does not move forward.

This is the failure mode vendors are misreading. The deal does not die because of competition or cost. It dies because the institution cannot justify saying yes.

The final section outlines what vendors need to change now to prevent this outcome and ensure their proof survives institutional review, not just departmental evaluation.

The evidence is clear that this is not a messaging problem that can be solved with better slides or more persuasive sales teams. It is a structural shift in how higher education institutions justify buying decisions under accreditation and compliance pressure. Vendors that continue to sell primarily to functional owners while treating governance as a late-stage hurdle will see more deals slow, shrink, or quietly fail.

The first change needs to happen in sales discovery. Vendors must stop assuming that accreditation and compliance are background conditions and start treating them as explicit buying drivers. This means surfacing questions early about how decisions will be reviewed, who will be involved beyond the sponsoring department, and what standards the institution must meet if the purchase is scrutinized later. Deals stall when these realities appear late. They move when vendors help institutions think through them upfront.

The second change is in what vendors treat as proof. Outcome metrics, case studies, and peer logos remain necessary but are no longer sufficient. Institutions increasingly need evidence that supports defensibility, not just effectiveness. That includes documentation practices, audit readiness, clarity on institutional ownership of processes and data, and an ability to explain how the solution fits within governance and accreditation frameworks. Vendors that cannot translate their value into those terms leave buyers with no way to justify the decision internally, regardless of functional fit.

Product and messaging strategy must also adjust. Compliance, governance, and audit support should not be framed as secondary benefits or legal footnotes. They need to be integrated into how the product is positioned and explained, particularly in categories touching data, assessment, AI, or student outcomes. At the same time, vendors should resist the temptation to overclaim alignment with accreditation standards. Institutions are highly sensitive to unsupported assertions. Credibility comes from clarity and restraint, not from broad promises.

Finally, GTM teams need to accept that longer sales cycles driven by governance review are not a temporary anomaly. Expanded stakeholder involvement, legal and audit sign-off, and higher proof thresholds are becoming permanent features of higher ed buying. Vendors that plan for this reality, invest in the right proof points, and align their sales motion to institutional risk dynamics will still close meaningful deals. Vendors that wait for the market to return to old norms will continue to misread delays as bad luck rather than as signals they failed to adapt.

Accreditation is not killing deals because institutions are buying less. It is killing deals because institutions can no longer afford to buy without being able to defend the decision. Vendors that help them do that will win. Those that do not will keep wondering why approved deals never close.

Higher Education Executive Intelligence is for strategy, product, and GTM leaders at vendors serving colleges, universities, and systems.

This is one of our six education and learning-related publications spanning K-12, Higher Education, and Workforce. Our education newsletters reach tens of thousands of senior decision-makers across the U.S. and key international markets.

Ping us if you’d like to learn more, explore Enterprise Subscriptions, or would like to partner in other ways.

The Intelligence Council is a next-gen B2B media and business intelligence platform built for people who make strategy, allocate capital, and carry operating risk.